Efficacy and safety of telaprevir with natural human interferon‐β and ribavirin in Japanese chronic hepatitis C patients with depression

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|48|2|184-192

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.48, Iss.2, 2018-02, pp. : 184-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 254-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 231-233

Karger

Access to resources Recommend Favorite

Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

By Garib Junia Rios Garcia Guilherme Freire Teixeira Rosâângela Lima e Silva Francisco das Chagas

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 8, 2011-08 ,pp. : 625-631

Informa Healthcare

Access to resources Recommend Favorite

Relative efficacy and safety of simeprevir and telaprevir in treatment‐naïve hepatitis C‐infected patients in a Japanese population: A Bayesian network meta‐analysis

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E89-E98

John Wiley & Sons Inc

Access to resources Recommend Favorite